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Summary.-Nineteen cases of malignant lymphomata were selected for study from
a group of about 1500 collected cases of malignant lymphomata because they showed
histological evidence of non-infectious epithelioid-cell granulomata in one or more
tissues.
In the 19 cases selected, 5 cases of systemic sarcoidosis, 4 cases of an associated
malignancy, 1 pre-malignant condition, and 1 case of an auto-immune disease
were found.
This remarkable association of sarcoid reactions or sarcoidosis with malignant
lymphomata and associated malignancies seems to justify speculation on the possi-
bility of a common aetiological factor, e.g. in the form of an altered immune reaction.
FOR many years it has been known
that in patients with Hodgkin's disease
non-caseating epithelioid-cell granulomata
(NCECG) may occur without any demon-
strable infectious or other exogenous
genesis (Bonenfent, 1954; Jackson and
Parker, 1947; Kadin et al., 1970; Nicker-
son, 1937; Pettet et al., 1955; Rappaport,
1966). In such patients these granulo-
mata may be found both in tissues directly
involved by Hodgkin's disease as well as
in uninvolved tissues; and as a rule no
clinical evidence of svstemic sarcoidosis
is present (Goldfarb and Cohen, 1970;
Hastings and Thompson, 1949; Herbeuval
et al., 1960; Kadin et al., 1970; Wurm
et al., 1958). In a small number of cases,
however, coexistence of " true " systemic
sarcoidosis and Hodgkin's disease, has
been reported, and in all these cases
sarcoidosis was diagnosed first (Goldfarb
and Cohen, 1970; Herbeuval et al., 1960;
Lamache et al., 1954; Pautrier, 1]934).
NCECG with (Atwood et al., 1966;
Buckle, 1960; Raben et al., 1961; Silver
et al., 1967) or without (Kissel et al.,
1962) clinical evidence of systemic sar-
coidosis have also been reported in
patientswithothermalignant lymphomata,
though less frequently, and again in these
cases wit,h coexistence of sarcoidosis and
malignant lymphoma the former disease
has been diagnosed first.
The significance of NCECG in some
patients with malignant lymphoma is still
obscure and the frequency of this finding
in different kinds of lymphomata is not
well known. In a recent series, however,
NCECG were found in 31 of 185 patients
with Hodgkin's disease (Kadin et al.,
1970). In the cases where NCECG have
been observed exclusively in the tissues
invaded by Hodgkin's disease, this finding
has been thought to represent an especially
hiighly differentiated variety of the histio-
cytic epithelioid-cell proliferation com-
monly occurring in Hodgkin's disease
(Bonenfent, 1954; Herbeuval et at., 1960;
Pautrier, 1934). The demonstration of
NCECG in uninvolved organs in patients
with malignantlymphomata has generated
speculation on a possible underlying
immunological mechanism (Atwood et al.,
1966; Brincker, 1970; Kadin et al., 1970)
or has been interpreted as sarcoid reactions
(Kadin et al., 1970; Kissel et al., 1962)
analogous to the sarcoid reactions occa-
sionally seen in lymph-nodes draining an
area involved with carcinoma (Gorton
and Linell, 1957; Nadel and Ackerman,
1950; Nickerson, 1937; Symmers, 1951).
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and malignant lymphoma has been con-
sidered accidental (Goldfarb and Cohen,
1970; Silver et al., 1967) or as an example
of malignant transformation of sarcoidosis
(Lamache et al., 1954; Raben et al.,
1961).
With one exception (Kadin et al.,
1970) the occurrence of NCECG in malig-
nant lymphomata has been described only
in casuistic reports or has been mentioned
only briefly in papers on histologic changes
in malignant lymphomata. A study based
on the observation and analysis of 19
cases of this kind therefore would seem
to be of some interest, particularly
because 5 of these patients presented
clinical evidence of systemic sarcoidosis.
MATERIALS AND COMIMENTS
NCECG have been demonstrated in
19 patients out of approximately 1500
cases of malignant lymphoma diagnosed
in 2 therapy centres during a 20-year
period. The cases diagnosed before 1967
were found more or less accidentally.
Since 1967, however, the presence of
these lesions has been carefully sought
in lymphoma patients. It is therefore
highly probable that a systematic revision
of all of the nearly 1500 cases would
uncover many more cases showing the
presence of NCECG. Six of the cases
(cases 5, 9, 13, 14, 15 and 17) have been
described in detail in an earlier report
(Brincker, 1970). The finding of 13
additional cases and the appearance of
more recent literature has provided
material for a re-evaluation and discussion
of the subject.
Table I shows the pertinent data
for 14 patients with malignant lympho-
mata and NCECG, but without clinical
evidence of sarcoidosis, while Table II
shows similar data for 5 patients with
malignant lymphomata (including chronic
lymphatic leucaemia) and clinical as well
as histological evidence of sarcoidosis.
NCECG occurred with all types of
malignant lymphomata but was asso-
ciated chiefly with Hodgkin's disease
(12 of the 19 cases). This agrees well
with the impression obtained from review-
ing the literature. Case 1 seems to be
the first reported example of follicular
lymphoma associated with NCECG. In
the cases without evidence of sarcoidosis
NCECG were found exclusively in the
tissues invaded by malignant lymphoma
in 7 patients, while NCECG were present
in both involved and uninvolved tissues
in the remaining 7 cases. In the latter
group the mediastinal lymph nodes and
the spleen were the most frequent sites.
Four of the 19 patients (cases 6, 14,
15 and 19) had a second malignant disease,
and in 3 of these cases the associated
malignancy preceded the diagnosis of
malignant lymphoma or sarcoidosis. Case
15 even presented a premalignant condi-
tion in addition to 2 malignancies and
sarcoidosis. In case 13 a diagnosis of
rheumatoid arthritis preceded the diag-
nosis ofHodgkin's disease, but no evidence
of auto-immune disease was found in the
remnaining 18 patients.
In 4 of the 5 patients with associated
malignancies or auto-immune disease
tuberculin allergy was demonstrated while
a subnormal serum globulin level was
found in 2 of these 5 patients. In the
remaining 14 patients no consistent pat-
tern of tuberculin reactivity or serum
globulin levels seems to be present.
In 2 of the patients without clinical
evidence of sarcoidosis (cases 1 and 13)
Kveim's test was performed with negative
results.
Anamnestic, clinical or serological evi-
dence of an infectious genesis of the
NCECG was carefully sought but not
found in any of the 19 patients.
In cases 17 and 18 there was unequi-
vocal clinical and histological evidence
of systemic sarcoidosis, 8 and 27 years
respectively, before malignant lymphoma
was diagnosed. In case 19 the diagnosis
of sarcoidosis was not verified histo-
logically but the clinical findings were so
typical that the diagnosis must be
regarded as highly probable. This patient
was treated for a carcinoma of the uterine
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cervix 15 years before sarcoidosis was
diagnosed and 29 years before chronic
lymphatic leucaemia was discovered.
Cases 15 and 16 are particularly
interesting because these 2 patients did
not present clinical evidence of sarcoidosis
until 5 and 17 years, respectively, after
the diagnosis of Hodgkin's disease. In
both patients the primary lymph-node
biopsy showed NCECG associated with
malignant changes of lymphoma, and in
both patients NCECG were demonstrated
in skin-biopsies after the appearance of
clinical signs of sarcoidosis. These
patients have been observed for 8 and
20 years, respectively, after the primary
treatment of Hodgkin's disease (cervical
lymph-node dissection + x-ray) without
evidence of recurrence of this disease.
In case 15 the diagnosis of sarcoidosis
was established after the appearance
of a brownish-red cutaneous sarcoid
lesion, containing NCECG, and the subse-
quent demonstration of a typical sarcoid-
like punch-out lesion in one of the meta-
tarsal bones of the left foot.
In case 16 the diagnosis of sarcoidosis
was made after the appearance of fever,
painful swelling of the joints and marked
bilateral enlargement of the hilar glands.
There were no visible skin-manifestations
but a skin-muscle biopsy from the left
calf demonstrated NCECG both in the
skin and in the connective tissue of the
muscle substance. LE-test, RA-test,
Rose-Waaler test, AST, ASH as well as
sero-reactions for mono-nucleosis, brucel-
losis, ornithosis, syphilis, and toxoplas-
rnosis turned out to be normal. Following
prednisone treatment for one month
all manifestations disappeared, and the
patient has remained well for 3 years
now. If the clinical findings had been
caused by recrudescent Hodgkin's disease
it is unlikely that the patient would still
remain in remission after such brief
prednisone treatment. Furthermore, the
demonstration of NCECG in the skin-
muscle biopsy supports the diagnosis
of systemic sarcoidosis since sarcoid reac-
tions associated with malignant tumours
have not been described with certainty
outside the reticulo-endothelial system
or the tissue directly involved with the
malignancy.
DISCUSSION
It is well known that a large number
of agents can give rise to the formation
of NCECG; and the isolated findings of
these histologic changes cannot be con-
sidered sufficient for the diagnosis of
systemic sarcoidosis when unsupported
by clinical evidence (Refvcm, 1954).
In cases 1-14 no clinical evidence of
systemic sarcoidosis was found during a
period of observation of up to 7 years
after the demonstration ofNCECG. Thus,
so far, the occurrence of NCECG in
these patients must tentatively be classi-
fied as sarcoid reactions.
The development of sarcoidosis in
cases 15 and 16 was unexpected and
could not have been predicted from the
clinical picture that existed when the
malignant lymphoma was first diagnosed.
If they had not been observed over an
extended period the occurrence ofNCECG
in the primary biopsies would have been
interpreted as sarcoid reactions. It would
seem quite possible that sarcoidosis existed
in a pre-clinical form in these 2 patients
at the time that malignant lymphoma
was first diagnosed. If this is so, this
groups them together with cases 17-19 in
which sarcoidosis was diagnosed before
a malignant lymphoma just as in all
the cases reported earlier (Atwood et al.,
1966; Buckle, 1960; Goldfarb and Cohen,
1970; Herbeuval et al., 1960; Lamache
et al., 1954; Pautrier, 1934; Raben et al.,
1961; Silver, 1967).
The question might be raised whether
pre-clinical sarcoidosis might not also
exist in cases 1-14. Only continued
observation of these cases can answer
this question. Neither a positive nor a
negative Kveim test is a reliable diag-
nostic guide, because of the possibility
of false-positive as well as false-negative
reactions.
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As an alternative interpretation of
cases 15 and 16 it might be suggested
that a non-specific sarcoid reaction could
give rise to a clinical picture, indistinguish-
able from that seen in " true " systemic
sarcoidosis. However, such an assump-
tion would make it difficult to maintain
the' concept of sarcoidosis as an inde-
pendent disease.
With an annual incidence ofsarcoidosis
in Denmark of 5 per 100,000 (Horwitz
et al., 1967) the finding of 5 patients
with sarcoidosis in a series of 1500
patients with malignant lymphomata ap-
pears to be well beyond The number that
might be expected. This association sug-
gests a connection between sarcoidosis
and malignantlymphomata. A connection
between sarcoidosis and Hodgkin's disease
has repeatedly been suspected on the
basis of similar clinical and immunological
findings in the two diseases (Jorgensen,
1964), but no convincing evidence of
such a relationship has so far been
presented.
In patients receiving intense-immuno-
suppressive treatment in order to prevent
the rejection of transplanted organs, an
abnormally high incidence of malignant
lymphomata and other malignancies has
been noted (Penn, 1970). Also in certain
rare hereditary- diseases associated with
immunological deficiency, e.g. ataxia-
teleangiectasia, Chediak-Higashi syn-
drome, Wiskott-Aldrich syndrome and
agammaglobulinaemia, an abnormally
high incidence of malignant lymphomata
and possibly of other malignancies has
been described (Doll and Kinlen, 1970;
Lynch, 1969). A similar association has
been observed in diseases with an altered
immune response such as dermatomyositis
(Williams, 1959), Sj6gren's syndrome
(Talal et al., 1967) and systemic lupus
erythematosus (Nilsen et al., 1967). These
findings have been considered to support
the hypothesis that one aspect of the
development of malignancies mnay be
related to a breakdown in immunological
surveillance (Doll and Kinlen, 1970;
Keast, 1970).
The immunological defect in sar-
coidosis involves both cell-mediated immu-
nity andimmunoglobulin synthesis (Chase,
1966). This suggests a relationship with
the conditions mentioned above and thus
raises the possibility that the immuno-
logical defect in sarcoidosis may somehow
lead to the development of malignancies,
especiallymalignantlymphomata, through
a breakdown in immunological surveil-
lance.
The findings of 4 cases of an associated
malignancy in this series of 19 cases
deserves special consideration. Informa-
tion on the frequency of multiple malig-
nancies may be derived partly from
autopsy material, partly from cases in
which multiple malignancies have been
found intra vitam. The reported frequency
of multiple malignancies in autopsy
material is generally higher for a number
of reasons than that reported in living
patients (Moertel et al., 1961). In the
latter group one of the highest incidence
figures has been reportedby these workers,
who found 4.6%/ cases with more than
one malignancy. Applied to the present
series of 19 patients this figure would
correspond to an expected number of
0 9 patients having more than one
malignancy. In a group of randomly
selected individuals with the same age
and sex distribution as in the present
series, the expected incidence of cancer
detected from birth to the end of the
observation period would be 1 28 per
19 patients, based on published Danish
cancer incidence rates (Clemmesen, 1964).
Not including the malignant lymphomata,
the 4 cases of associated malignancy
(plus one premalignant condition) appear
to be at least three times the expected
number. It is possible, however, that
this apparently high incidence is for-
tuitous.
In 3 of the 4 cases of multiple malig-
nancies the associated malignancy was
diagnosedbeforethe malignantlymphoma,
and in the 2 cases also associated with
sarcoidosis, the associated malignancy
was diagnosed before either sarcoidosis
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or malignant lymphoma. The associated
malignancy cannot be viewed as a
consequence of sarcoidosis unless a pre-
clinical form of sarcoidosis is assumed in
all 4 patients. (This, however, is not
impossible, cf. cases 15 and 16.) Another
possible explanation might be that an
underlying immunological disturbance
accompanied by defective immunological
surveillance, gives rise to the develop-
ment of one or more malignant diseases
as well as the development of sarcoidosis
or sarcoid reactions.
The above speculations consider malig-
nant disease to be the result ofsarcoidosis,
or both malignant disease and sarcoid
reactions the result of an underlying
altered immune reaction. Previous views,
on the contrary, have held that sarcoid
reactions are a consequence of malignant
disease. Thus, in the latter case, it has
been suggested that metabolic products
from the tumour somehow give rise to
the mainly regional sarcoid reactions
(Gorton and Linell, 1957; Symmers, 1951).
An associated malignancy preceded sar-
coidosis or sarcoid reaction in 3 of the 4
cases and the question may be posed
in case 14 whether the preceding malig-
nancy could be the cause of the NCECG
later demonstrated in the liver, spleen and
bone marrow in this patient. However,
in cases 15 and 19 with unequivocal
clinical evidence ofsarcoidosis the NCECG
present cannot be considered a mere
sarcoid reaction unless the concept of
" true " systemic sarcoidosis as a disease
sui generis is challenged.
The 3 cases of associated malignancy,
preceding malignant lymphomata by 1, 5
and 29 years, respectively, had been
cured by radiotherapy. It must be con-
sidered, therefore, whether the radio-
therapy given could be apossible causative
factor in the ensuing development of
Hodgkin's disease in cases 14 and 15
and chronic lymphatic leukaemia in case
19. Such an assumption appears reason-
able in case 19, the interval between
radiotherapy and diagnosis of leukaemia
being 29 years. It should be remembered,
however, that similar causative factors
have also been involved in the cases from
which the frequencies of multiple malig-
nancies have been calculated (Moertel et
al., 1961).
In view of the increased incidence
of malignant lymphomata in patients
with auto-immune disorders (Lynch, 1969;
Nilsen et al., 1967; Talal et al., 1967;
Williams, 1959) it is of interest that one
of the patients (case 13) was treated for
rheumatoid arthritis 4 years before Hodg-
kin's disease was diagnosed. This case
was the only example of an auto-immune
disease in the series, and the association
with Hodgkin's disease may have been
quite fortuitous. It should be mentioned,
however, that a significantly increased
frequency of preceding rheumatic disease
has been found in patients with all types
of lymphomata (Lea, 1964).
In 19 cases of malignant lymphomata,
selected for study because of the demon-
stration ofNCECG in one or more tissues,
it seems remarkable to find 5 cases of
systemic sarcoidosis, 4 cases of an asso-
ciated malignancy, 1 premalignant condi-
tion and 1 case ofan auto-immune disease.
Taken separately each of these mani-
festations could be considered fortuitous,
but viewed together they seem to justify
speculation on the possibility ofa common
etiological factor, e.g. in the form of an
altered immune reaction.
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